C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/113 (2010.01) C12N 5/10 (2006.01) C12N 15/63 (2006.01)
Patent
CA 2752239
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Glial cell derived neurotrophic factor (GDNF), in particular, by targeting natural antisense polynucleotides of Glial cell derived neurotrophic factor (GDNF). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of GDNF.
La présente invention concerne les oligonucléotides antisens qui modulent l'expression et/ou la fonction du facteur neurotrophique dérivé des cellules gliales (GDNF), en particulier en ciblant les polynucléotides antisens naturels dudit facteur neurotrophique dérivé des cellules gliales (GDNF). L'invention porte également sur l'identification desdits oligonucléotides antisens et sur leur utilisation dans le cadre du traitement des maladies et troubles associés à l'expression du GDNF.
Coito Carlos
Collard Joseph
Khorkova Sherman Olga
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Opko Curna Llc
LandOfFree
Treatment of glial cell derived neurotrophic factor (gdnf)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of glial cell derived neurotrophic factor (gdnf)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of glial cell derived neurotrophic factor (gdnf)... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1662510